Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-027269
Filing Date
2024-11-19
Accepted
2024-11-19 18:46:31
Documents
1
Period of Report
2024-11-15

Document Format Files

Seq Description Document Type Size
1 form4-11192024_111127.html 4  
1 form4-11192024_111127.xml 4 12998
  Complete submission text file 0001415889-24-027269.txt   14401
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Issuer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 25 WEST WATKINS MILL ROAD, SUITE A GAITHERSBURG MD 20878
Business Address
Gilson Michelle (Reporting) CIK: 0001930862 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41259 | Film No.: 241477772